157 related articles for article (PubMed ID: 22231877)
1. [Rifaximin for hepatic encephalopathy in children. Case report].
Malla I; Torres Cerino V; Villa A; Cheang Y; Giacove G; Pedreira A; Silva M
Arch Argent Pediatr; 2011 Dec; 109(6):e113-5. PubMed ID: 22231877
[TBL] [Abstract][Full Text] [Related]
2. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
Williams R; Bass N
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin: a nonabsorbed oral antibiotic.
Baker DE
Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL; DuPont HL
Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of rifaximin in management of hepatic encephalopathy.
Wahib AA; El-Deen Salem MN; Ahmed MA; El-Dessouky YM; El-Tiby DM; El-Mola K; El-Sayed AM
J Egypt Soc Parasitol; 2014 Dec; 44(3):677-85. PubMed ID: 25643509
[TBL] [Abstract][Full Text] [Related]
6. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
Rigali VT
Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
[No Abstract] [Full Text] [Related]
7. Rifaximin: new therapeutic indication and future directions.
Rivkin A; Gim S
Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
[TBL] [Abstract][Full Text] [Related]
8. Editorial: prolonged remission from hepatic encephalopathy with rifaximin.
Orr JG; Hudson M
Aliment Pharmacol Ther; 2015 Jan; 41(2):228. PubMed ID: 25511766
[No Abstract] [Full Text] [Related]
9. Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis.
Neff GW; Jones M; Jonas M; Ravinuthala R; Novick D; Kaiser TE; Kemmer N
J Clin Gastroenterol; 2013 Feb; 47(2):188-92. PubMed ID: 23314671
[TBL] [Abstract][Full Text] [Related]
10. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
[No Abstract] [Full Text] [Related]
11. Rifaximin for the treatment of hepatic encephalopathy.
Lawrence KR; Klee JA
Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
Adachi JA; DuPont HL
Clin Infect Dis; 2006 Feb; 42(4):541-7. PubMed ID: 16421799
[TBL] [Abstract][Full Text] [Related]
13. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
Mas A; Rodés J; Sunyer L; Rodrigo L; Planas R; Vargas V; Castells L; Rodríguez-Martínez D; Fernández-Rodríguez C; Coll I; Pardo A;
J Hepatol; 2003 Jan; 38(1):51-8. PubMed ID: 12480560
[TBL] [Abstract][Full Text] [Related]
14. Durability of rifaximin response in hepatic encephalopathy.
Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].
Gasztonyi B; Hunyady B
Orv Hetil; 2004 Oct; 145(43):2177-81. PubMed ID: 15575494
[TBL] [Abstract][Full Text] [Related]
16. [Rifaximin in the treatment of hepatic encephalopathy].
Lata J; Hůlek P; Fejfar T; Spicák J; Drastich P; Marecek Z; Brůha R; Husová L; Senkyrík M
Vnitr Lek; 2002 Jun; 48(6):578-82. PubMed ID: 12132365
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.
Kok B; Foxton MR; Clough C; Shawcross DL
Hepatology; 2013 Oct; 58(4):1516-7. PubMed ID: 23471844
[No Abstract] [Full Text] [Related]
18. Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis.
Bajaj JS; Barrett AC; Bortey E; Paterson C; Forbes WP
Aliment Pharmacol Ther; 2015 Jan; 41(1):39-45. PubMed ID: 25339518
[TBL] [Abstract][Full Text] [Related]
19. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin therapy and Clostridium difficile infection: a note of caution.
Zullo A; Ridola L; Hassan C
J Clin Gastroenterol; 2013 Sep; 47(8):737. PubMed ID: 23507769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
